Skip to main content
Top
Published in: PharmacoEconomics - Open 4/2017

Open Access 01-12-2017 | Current Opinion

Statistical Alchemy: Conceptual Validity and Mapping to Generate Health State Utility Values

Authors: Jeff Round, Annie Hawton

Published in: PharmacoEconomics - Open | Issue 4/2017

Login to get access

Abstract

Mapping between non-preference- and preference-based health-related quality-of-life instruments has become a common technique for estimating health state utility values for use in economic evaluations. Despite the increased use of mapped health state utility estimates in health technology assessment and economic evaluation, the methods for deriving them have not been fully justified. Recent guidelines aim to standardise reporting of the methods used to map between instruments but do not address fundamental concerns in the underlying conceptual model. Current mapping methods ignore the important conceptual issues that arise when extrapolating results from potentially unrelated measures. At the crux of the mapping problem is a question of validity; because one instrument can be used to predict the scores on another, does this mean that the same preference for health is being measured in actual and estimated health state utility values? We refer to this as conceptual validity. This paper aims to (1) explain the idea of conceptual validity in mapping and its implications; (2) consider the consequences of poor conceptual validity when mapping for decision making in the context of healthcare resource allocation; and (3) offer some preliminary suggestions for improving conceptual validity in mapping.
Literature
2.
go back to reference EuroQol Group. EQ-5D user guide. Rotterdam: The EuroQol Group; 1996. EuroQol Group. EQ-5D user guide. Rotterdam: The EuroQol Group; 1996.
3.
go back to reference Brazier J, Yang Y, Tsuchiya A, Rowen D. A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures. Eur J Health Econ. 2010;11(2):215–25.CrossRefPubMed Brazier J, Yang Y, Tsuchiya A, Rowen D. A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures. Eur J Health Econ. 2010;11(2):215–25.CrossRefPubMed
4.
go back to reference National Institute for Health and Care Excellence. Guide to the methods of technology appraisal 2008. Manchester: National Institute for Health and Care Excellence; 2008. National Institute for Health and Care Excellence. Guide to the methods of technology appraisal 2008. Manchester: National Institute for Health and Care Excellence; 2008.
5.
go back to reference National Institute for Health and Care Excellence. Guide to the methods of technology appraisal 2013. Manchester: National Institute for Health and Care Excellence; 2013. National Institute for Health and Care Excellence. Guide to the methods of technology appraisal 2013. Manchester: National Institute for Health and Care Excellence; 2013.
6.
go back to reference Mortimer D, Segal L. Comparing the incomparable? A systematic review of competing techniques for converting descriptive measures of health status into QALY-weights. Med Decis Mak. 2008;28(1):66-89. doi:10.1177/0272989X07309642.CrossRef Mortimer D, Segal L. Comparing the incomparable? A systematic review of competing techniques for converting descriptive measures of health status into QALY-weights. Med Decis Mak. 2008;28(1):66-89. doi:10.​1177/​0272989X07309642​.CrossRef
7.
go back to reference Petrou S, Rivero-Arias O, Dakin H, Longworth L, Oppe M, Froud R, et al. Preferred reporting items for studies mapping onto preference-based outcome measures: the MAPS statement. Pharmacoeconomics. 2015;33(10):985–91.CrossRefPubMedPubMedCentral Petrou S, Rivero-Arias O, Dakin H, Longworth L, Oppe M, Froud R, et al. Preferred reporting items for studies mapping onto preference-based outcome measures: the MAPS statement. Pharmacoeconomics. 2015;33(10):985–91.CrossRefPubMedPubMedCentral
8.
go back to reference McCabe C, Edlin R, Meads D, Brown C, Kharroubi S. Constructing indirect utility models: some observations on the principles and practice of mapping to obtain health state utilities. Pharmacoeconomics. 2013;31(8):635–41.CrossRefPubMed McCabe C, Edlin R, Meads D, Brown C, Kharroubi S. Constructing indirect utility models: some observations on the principles and practice of mapping to obtain health state utilities. Pharmacoeconomics. 2013;31(8):635–41.CrossRefPubMed
9.
go back to reference Petrou S, Rivero-Arias O, Dakin H, Longworth L, Oppe M, Froud R, et al. The maps reporting statement for studies mapping onto generic preference-based outcome measures. Value Health. 2015;18(7):A715–6.CrossRefPubMed Petrou S, Rivero-Arias O, Dakin H, Longworth L, Oppe M, Froud R, et al. The maps reporting statement for studies mapping onto generic preference-based outcome measures. Value Health. 2015;18(7):A715–6.CrossRefPubMed
11.
go back to reference Hernandez Alava M, Wailoo A, Wolfe F, Michaud K. A comparison of direct and indirect methods for the estimation of health utilities form clinical outcomes. HEDS Discussion Paper 12. Sheffield: University of Sheffield; 2012. Hernandez Alava M, Wailoo A, Wolfe F, Michaud K. A comparison of direct and indirect methods for the estimation of health utilities form clinical outcomes. HEDS Discussion Paper 12. Sheffield: University of Sheffield; 2012.
12.
go back to reference Lu G, Brazier J, Ades A. Mapping from disease-specific to generic health-related quality-of-life scales: a common factor model. Value Health. 2013;16(1):177–84.CrossRefPubMed Lu G, Brazier J, Ades A. Mapping from disease-specific to generic health-related quality-of-life scales: a common factor model. Value Health. 2013;16(1):177–84.CrossRefPubMed
13.
go back to reference Brazier J, Roberts J, Deverill M. The estimation of a preference-based single index measure for health from the SF-36. J Health Econ. 2002;21:271–92.CrossRefPubMed Brazier J, Roberts J, Deverill M. The estimation of a preference-based single index measure for health from the SF-36. J Health Econ. 2002;21:271–92.CrossRefPubMed
14.
go back to reference Brazier J, Roberts J. The estimation of a preference-based measure of health from the SF-12. Med Care. 2004;42(9):851–9.CrossRefPubMed Brazier J, Roberts J. The estimation of a preference-based measure of health from the SF-12. Med Care. 2004;42(9):851–9.CrossRefPubMed
15.
go back to reference Skevington SM. Investigating the relationship between pain and discomfort and quality of life, using the WHOQOL. Pain. 1998;76(3):395–406.CrossRefPubMed Skevington SM. Investigating the relationship between pain and discomfort and quality of life, using the WHOQOL. Pain. 1998;76(3):395–406.CrossRefPubMed
16.
go back to reference Juniper E, Buist S, Cox F, Ferrie P, King D. Validation of a standardised version of the Asthma Quality of Life Questionnaire. Chest. 1999;115:1265–70.CrossRefPubMed Juniper E, Buist S, Cox F, Ferrie P, King D. Validation of a standardised version of the Asthma Quality of Life Questionnaire. Chest. 1999;115:1265–70.CrossRefPubMed
17.
go back to reference Brazier J, Ratcliffe J, Salomon J, Tsuchiya A. Measuring and valuing health benefits for economic evaluation. Oxford: Oxford University Press; 2007. Brazier J, Ratcliffe J, Salomon J, Tsuchiya A. Measuring and valuing health benefits for economic evaluation. Oxford: Oxford University Press; 2007.
18.
go back to reference Wailoo AJ, Hernandez-Alava M, Manca A, Mejia A, Ray J, Crawford B, et al. Mapping to estimate health-state utility from non-preference-based outcome measures: an ISPOR Good Practices for Outcomes Research Task Force Report. Value Health. 2017;20(1):18–27.CrossRefPubMed Wailoo AJ, Hernandez-Alava M, Manca A, Mejia A, Ray J, Crawford B, et al. Mapping to estimate health-state utility from non-preference-based outcome measures: an ISPOR Good Practices for Outcomes Research Task Force Report. Value Health. 2017;20(1):18–27.CrossRefPubMed
19.
go back to reference Longworth L, Buxton M, Sculpher M, Smith D. Estimating utility data from clinical indicators for patients with stable angina. Eur J Health Econ. 2005;6:347–53.CrossRefPubMed Longworth L, Buxton M, Sculpher M, Smith D. Estimating utility data from clinical indicators for patients with stable angina. Eur J Health Econ. 2005;6:347–53.CrossRefPubMed
20.
go back to reference Campeau L. Letter: grading of angina pectoris. Circulation. 1976;54(3):522–3.PubMed Campeau L. Letter: grading of angina pectoris. Circulation. 1976;54(3):522–3.PubMed
21.
go back to reference Fredriksson T, Pettersson U. Severe psoriasis: oral therapy with a new retinoid. Dermatologica. 1978;157(4):238–44.CrossRefPubMed Fredriksson T, Pettersson U. Severe psoriasis: oral therapy with a new retinoid. Dermatologica. 1978;157(4):238–44.CrossRefPubMed
22.
go back to reference Round J. Capturing information loss in estimates of uncertainty that arise from mapping algorithms. Aberdeen: Health Economists’ Study Group; 2008. Round J. Capturing information loss in estimates of uncertainty that arise from mapping algorithms. Aberdeen: Health Economists’ Study Group; 2008.
23.
go back to reference Hawton A, Green C, Telford C, Wright D, Zajicek J. The use of multiple sclerosis condition-specific measures to inform health policy decision-making: mapping from the MSWS-12 to the EQ-5D. Mult Scler J. 2012;18(6):853–61.CrossRef Hawton A, Green C, Telford C, Wright D, Zajicek J. The use of multiple sclerosis condition-specific measures to inform health policy decision-making: mapping from the MSWS-12 to the EQ-5D. Mult Scler J. 2012;18(6):853–61.CrossRef
24.
go back to reference Hawton A, Green C, Telford C, Zajicek J, Wright D. Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, Version 2, to the EQ-5D and the SF-6D. Value Health. 2012;15:1084–91.CrossRefPubMed Hawton A, Green C, Telford C, Zajicek J, Wright D. Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, Version 2, to the EQ-5D and the SF-6D. Value Health. 2012;15:1084–91.CrossRefPubMed
25.
go back to reference Hobart J, Lamping D, Fitzpatrick R, Riazi A, Thompson A. The Multiple Sclerosis Impact Scale (MSIS-29). A new patient-based outcome measure. Brain. 2001;124:962–73.CrossRefPubMed Hobart J, Lamping D, Fitzpatrick R, Riazi A, Thompson A. The Multiple Sclerosis Impact Scale (MSIS-29). A new patient-based outcome measure. Brain. 2001;124:962–73.CrossRefPubMed
26.
go back to reference Hobart J, Cano S. Improving the evaluation of therapeutic interventions in multiple sclerosis: the role of new psychometric methods. Health Technol Assess. 2009;13(12):iii, ix–x, 1–177. Hobart J, Cano S. Improving the evaluation of therapeutic interventions in multiple sclerosis: the role of new psychometric methods. Health Technol Assess. 2009;13(12):iii, ix–x, 1–177.
27.
go back to reference Hobart J, Riazi A, Lamping D, Fitzpatrick R, Thompson A. Measuring the impact of MS on walking ability: the 12-item MS Walking Scale (MSWS-12). Neurology. 2003;60:31–6.CrossRefPubMed Hobart J, Riazi A, Lamping D, Fitzpatrick R, Thompson A. Measuring the impact of MS on walking ability: the 12-item MS Walking Scale (MSWS-12). Neurology. 2003;60:31–6.CrossRefPubMed
28.
go back to reference Longworth L, Yang Y, Rowen D, Tsuchiya A, Young T, Brazier J. Development and valuation of a vision bolt-on to EQ-5D. Exeter: University of Exeter; 2013. Longworth L, Yang Y, Rowen D, Tsuchiya A, Young T, Brazier J. Development and valuation of a vision bolt-on to EQ-5D. Exeter: University of Exeter; 2013.
29.
go back to reference Gray A, Rivero-Arias O, Clarke P. Estimating the association between SF-12 responses and EQ-5D utility values by response mapping. Med Decis Mak. 2006;26:18–29.CrossRef Gray A, Rivero-Arias O, Clarke P. Estimating the association between SF-12 responses and EQ-5D utility values by response mapping. Med Decis Mak. 2006;26:18–29.CrossRef
30.
go back to reference Edlin R, Tsuchiya A, Brazier J. Mapping the Minnesota Living with Heart Failure Questionnaire to the EQ-5D index. Sheffield: University of Sheffield; 2002. Edlin R, Tsuchiya A, Brazier J. Mapping the Minnesota Living with Heart Failure Questionnaire to the EQ-5D index. Sheffield: University of Sheffield; 2002.
31.
go back to reference Tsuchiya A, Brazier J, McColl E, Parkin D. Deriving preference-based single indices from non-preference based condition specific instruments: converting AQLQ into EQ-5D indices. HEDS discussion paper. Sheffield: University of Sheffield; 2002. Tsuchiya A, Brazier J, McColl E, Parkin D. Deriving preference-based single indices from non-preference based condition specific instruments: converting AQLQ into EQ-5D indices. HEDS discussion paper. Sheffield: University of Sheffield; 2002.
32.
go back to reference Rivero-Arias O, Ouellet M, Gray A, Wolstenholme J, Rothwell P, Luengo-Fernandez R. Mapping the modified Rankin scale (mRS) measurement into the generic EuroQol (EQ-5D) health outcome. Med Decis Mak. 2010;30(3):341–54.CrossRef Rivero-Arias O, Ouellet M, Gray A, Wolstenholme J, Rothwell P, Luengo-Fernandez R. Mapping the modified Rankin scale (mRS) measurement into the generic EuroQol (EQ-5D) health outcome. Med Decis Mak. 2010;30(3):341–54.CrossRef
33.
go back to reference Dakin H, Gray A, Murray D. Mapping analyses to estimate EQ-5D utilities and responses based on Oxford Knee Score. Qual Life Res. 2013;22(3):683–94.CrossRefPubMed Dakin H, Gray A, Murray D. Mapping analyses to estimate EQ-5D utilities and responses based on Oxford Knee Score. Qual Life Res. 2013;22(3):683–94.CrossRefPubMed
35.
go back to reference Chuang L, Kind P. Converting the SF-12 into the EQ-5D: an empirical comparison of methodologies. Pharmacoeconomics. 2009;27(6):491–505.CrossRefPubMed Chuang L, Kind P. Converting the SF-12 into the EQ-5D: an empirical comparison of methodologies. Pharmacoeconomics. 2009;27(6):491–505.CrossRefPubMed
36.
go back to reference Parkin D, Rice N, Devlin N. Statistical analysis of EQ-5D profiles: does the use of value sets bias inference? Med Decis Mak. 2010;30(5):556–65.CrossRef Parkin D, Rice N, Devlin N. Statistical analysis of EQ-5D profiles: does the use of value sets bias inference? Med Decis Mak. 2010;30(5):556–65.CrossRef
37.
go back to reference Streiner D, Norman G. Health measurement scales. 3rd ed. Oxford: Oxford University Press; 2003. Streiner D, Norman G. Health measurement scales. 3rd ed. Oxford: Oxford University Press; 2003.
38.
go back to reference Dowie J. Decision validity should determine whether a generic or condition-specific HRQOL measure is used in health care decisions. Health Econ. 2004;11(1):1–8.CrossRef Dowie J. Decision validity should determine whether a generic or condition-specific HRQOL measure is used in health care decisions. Health Econ. 2004;11(1):1–8.CrossRef
Metadata
Title
Statistical Alchemy: Conceptual Validity and Mapping to Generate Health State Utility Values
Authors
Jeff Round
Annie Hawton
Publication date
01-12-2017
Publisher
Springer International Publishing
Published in
PharmacoEconomics - Open / Issue 4/2017
Print ISSN: 2509-4262
Electronic ISSN: 2509-4254
DOI
https://doi.org/10.1007/s41669-017-0027-2

Other articles of this Issue 4/2017

PharmacoEconomics - Open 4/2017 Go to the issue

Acknowledgement to Referees

Acknowledgement to Referees